NCT00668382View on ClinicalTrials.gov

Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Neoplasm Metastases
Interventions
BIOLOGICAL

Alpha-Gal Glycosphingolipid

Intra-tumoral injection of Alpha-Gal Glycosphingolipid to evaluate toxicity

Trial Locations (1)

01655-0108

University of Massachusetts Medical School, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT00668382 - Evaluate The Toxicity And Feasibility Of Intra-Tumoral Injection | Biotech Hunter | Biotech Hunter